Relationship Between Maternal Bone Biomarkers and Fetal Adiposity Through Normal Pregnancy.
George MastorakosDimosthenis MaliopoulosSpyridoula KasioniAlexandra BargiotaThomas M BarberChrysanthi SkevakiIoannis PapassotiriouNikos VrachnisGeorge FarmakidesNikos F VlahosSudhesh KumarGeorgios ValsamakisPublished in: The Journal of clinical endocrinology and metabolism (2021)
Maternal bone markers sclerostin and sRANKL may relate to fetal intra-abdominal adipose tissue deposition through as yet unknown direct or indirect mechanisms, thus contributing to birthweight.